LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

LLY

805.71

-1.45%↓

UNH

556.95

-1.68%↓

JNJ

158.12

-1.16%↓

NVO

109.92

-1.81%↓

ABBV

200.71

-1.24%↓

Accueil・Liste d'Actions・Royalty Pharma PLC (Class A)

Royalty Pharma PLC (Class A)

Fermé

27.08 0.3

Acheter Vendre

Résumé

Variation du prix de l'action

24h

Actuel

Min

27.04

Max

27.21

Recommandations
By TipRanks
Recommandations	Achat Fort
Prévisions sur 12 Mois	+63.84 upside

Dividendes
By Dow Jones
Prochains Résultats	6 nov. 2024
Date du Prochain Dividende	10 déc. 2024
Date du Prochain Détachement de Dividende	15 nov. 2024

Score Technique

By Trading Central

Confiance

Strong Bearish Evidence

26.95 / 27.322 Support & Résistance

Royalty Pharma PLC (Class A) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

1 nov. 2024, 22:50 UTC

Actions en Tendance

Stocks to Watch: Nvidia, Intel, Sherwin-Williams, Dow, Nuwellis

1 nov. 2024, 22:43 UTC

Principaux Mouvements du Marché

Nvidia, Sherwin-Williams Shares Up on Addition to DJIA

1 nov. 2024, 22:13 UTC

Principaux Mouvements du Marché

Chewy Up 5% on S&P MidCap 400 Inclusion

1 nov. 2024, 21:39 UTC

Résultats

Insurance Company Chubb Projects Up to $300 Million Pre-Tax Loss on Hurricane

2 nov. 2024, 13:53 UTC

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- Update

2 nov. 2024, 13:44 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 13:00 UTC

Résultats

China's EV Makers Set Sights on Latin America in Global Expansion -- WSJ

2 nov. 2024, 12:58 UTC

Résultats

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 12:48 UTC

Résultats

Acquisitions, Fusions, Rachats

Warren Buffett's Berkshire Hathaway Slashes Apple Stake Again -- WSJ

2 nov. 2024, 12:32 UTC

Résultats

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2 nov. 2024, 12:28 UTC

Acquisitions, Fusions, Rachats

Berkshire Sold 25% of Its Apple Stock in the Third Quarter -- Barrons.com

2 nov. 2024, 12:17 UTC

Résultats

Berkshire Profits Fell 6% in Third Quarter. The Buybacks Are on Pause. -- Barrons.com

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q EPS $18272.00 >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q BNSF Operating Earnings $1.38B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Berkshire Hathaway Energy Company Operating Earnings $1.63B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Insurance-Underwriting Operating Earnings $750M >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Other Operating Loss $877M >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Insurance-Investment Income Operating Earnings $3.66B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Net $26.25B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Other Controlled Businesses Operating Earnings $3.34B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Non-Controlled Businesses Operating Earnings $199M >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Operating Earnings $10.09B >BRKA

2 nov. 2024, 12:00 UTC

Résultats

Berkshire Hathaway 3Q Investment, Derivative Gains $16.16B >BRKA

2 nov. 2024, 09:30 UTC

Actualités

Awful Jobs Report Aside, the Economy Is Still Strong -- Heard on the Street -- WSJ

2 nov. 2024, 08:20 UTC

Market Talk

Résultats

Tech, Media & Telecom Roundup: Market Talk

2 nov. 2024, 08:20 UTC

Market Talk

Résultats

Auto & Transport Roundup: Market Talk

1 nov. 2024, 22:51 UTC

Résultats

Correction to Nvidia to Replace Intel in Dow Jones Industrial Average Article -- WSJ

1 nov. 2024, 22:00 UTC

Actualités

Résultats

Nvidia to Replace Intel in Dow Jones Industrial Average. Sherwin-Williams Also Joins. -- WSJ

1 nov. 2024, 21:29 UTC

Actualités

Résultats

Exxon and Chevron Feel Brunt of Cheaper Oil -- 2nd Update

1 nov. 2024, 21:24 UTC

Résultats

Insurance Company Chubb Projects Up to $300M Pre-Tax Loss on Hurricane

Comparaison

Variation de prix

Royalty Pharma PLC (Class A) prévision

Objectif de Prix

By TipRanks

63.84% hausse

Prévisions sur 12 Mois

Moyen 44.4 USD 63.84%

Haut 51 USD

Bas 38 USD

Basé sur 5 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Achat Fort

5 ratings

Achat

Maintien

Vente

Basé sur 5 qui ont noté l'action Microsoft Corp. au cours des 3 derniers mois.

Score Technique

By Trading Central

26.95 / 27.322Support & Résistance

Bearish events outweigh bullish events.

Recent bearish events outweigh bullish events.

All events are bearish.

Éléments financiers

Autres valeurs du secteur

LLY

Eli Lilly and Co.

805.71

↓-1.45%

UNH

UnitedHealth Group Inc

556.95

↓-1.68%

JNJ

Johnson and Johnson

158.12

↓-1.16%

NVO

Novo Nordisk A-S

109.92

↓-1.81%

ABBV

AbbVie Inc

200.71

↓-1.24%

Royalty Pharma PLC (Class A)

Résumé

Variation du prix de l'action

Recommandations

Dividendes

Score Technique

Royalty Pharma PLC (Class A) Graphique

Actualités Associées

Comparaison

Royalty Pharma PLC (Class A) prévision

Objectif de Prix

Note du Consensus

Score Technique

Éléments financiers

Autres valeurs du secteur

Informations cruciales sur les comptes Facebook